WASHINGTON — As 200 health care data wonks packed into a room just a block from the White House to consider the question of how to use “real world” data to do clinical research, they struggled with the fact that the health care system has been generating reams of data unfit for that specific purpose.
“What we have is an [electronic health record] system that is not primarily built for research, and yet we need to see if we can use it for research,” Rich Moscicki, the Food and Drug Administration’s deputy center director for science operations at the Center for Drug Evaluation and Research, told STAT. In October Moscicki will join Pharmaceutical Research and Manufacturers of America as the trade group’s chief medical officer and executive vice president.
